A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia

NCT05353192 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Achondroplasia

Interventions

DRUG: Recombinant human growth hormone

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]